Hearing loss among U.S. adults aged 20 to 69 has declined over the last decade, even as the number of older Americans continues to grow.
Christmas came early for Gerald Kopitowski – in July he was given four months to live after being diagnosed with aggressive oral cancer that ravaged his tongue and throat, preventing him from eating and talking, and eventually breathing. He lost 80 lbs. in mere months.
Changes To Gene Activity That Occur With Age Can Be Turned Back, A New Study Shows
Nanomix, Inc. has revealed the first rapid diagnostic test panel designed to quickly evaluate patients affected by sepsis, which runs on the company’s simple-to-use, handheld diagnostic system, the Nanomix eLab.
Treating psychotic illnesses cost the province of Ontario just under $2.1 billion in 2012, which was about four per cent of the total provincial health budget, according to a new study from the Institute for Clinical Evaluative Sciences (ICES) and Centre for Addiction and Mental Health (CAMH).
The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
The U.S. Food and Drug Administration today approved Maci (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients. Maci is the first FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient’s own knee.
Galderma, a global leader focused on medical solutions in skin health, has announced that it has received U.S. Food and Drug Administration (FDA) approval of two new products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21.1,2 Restylane® Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane® Defyne for the treatment of moderate to severe, deep facial wrinkles and folds.1,2
The National Institutes of Health Common Fund has announced the first awards for the Molecular Transducers of Physical Activity in Humans Program, which will allow researchers to develop a comprehensive map of the molecular changes that occur in response to physical activity.
Researchers developing drugs against polio and other polio-like viruses say those drugs could potentially be effective against a mysterious, polio-like condition called acute flaccid myelitis (AFM).